Oren Plous, MD
Retina Specialist · Sarasota, FLNPI 1467422659
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Cardinal Health 108 LLC at 58.1% of the total. Reporting peaked in 2020 at $1,644 and has fallen 85.4% since, to $240 in 2025. That places this record below the midpoint for retina specialist clinicians in FL, where the typical reported total is $2,986.
Across 34 payments — averaging $79.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 108 LLC$2K
- Regeneron Healthcare Solutions, Inc.$379
- Harrow Eye, LLC$135
- Apellis Pharmaceuticals, Inc.$122
- Alcon$113
- Astellas Pharma US Inc$94
- plus $291 from 11 others
What the payments were for
- Consulting fees$1,57558%
- Food & beverage$1,09540%
- Gifts$391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 108 LLC | 1 | $1,575 |
| Regeneron Healthcare Solutions, Inc. | 9 | $379 |
| Harrow Eye, LLC | 4 | $135 |
| Apellis Pharmaceuticals, Inc. | 1 | $122 |
| Alcon | 2 | $113 |
| Astellas Pharma US Inc | 4 | $94 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $75 |
| Carl Zeiss Meditec AG | 2 | $39 |
| AbbVie | 2 | $30 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Alimera Sciences, Inc. | 1 | $21 |
| Ocular Therapeutix, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Novartis | 1 | $16 |
| Omeros Corporation | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,709 in reported general payments places this provider in the 45th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 97 | $3,534 |
| Ketorolac Tromethamine | 69 | $2,158 |
| Brimonidine Tartrate | 28 | $960 |
| Dorzolamide Hcl | 41 | $788 |
| Latanoprost | 80 | $781 |
| Ofloxacin | 16 | $156 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $130 |
| Timolol Maleate | 15 | $51 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Sarasota
- Keye WongSarasota$23K
- Tanuj BankerSarasota$16K
- John NiffeneggerSarasota$16K
- Elizabeth RichterSarasota$15K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.